{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:47:09Z","timestamp":1791985629225,"version":"4.4.0"},"reference-count":38,"publisher":"American Society for Microbiology","issue":"10","license":[{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"name":"NHMRC Investigator Grant","award":["GNT2033078"],"award-info":[{"award-number":["GNT2033078"]}]},{"name":"NHMRC Investigator Grant","award":["GNT2033299"],"award-info":[{"award-number":["GNT2033299"]}]},{"name":"NHMRC Investigator Grant","award":["GNT2033803"],"award-info":[{"award-number":["GNT2033803"]}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2026,10,14]]},"abstract":"ABSTRACT<\/jats:title>\n \n \n \n The implementation of HIV pre-exposure prophylaxis and doxycycline post-exposure prophylaxis may influence antimicrobial resistance in\n Neisseria gonorrhoeae<\/jats:italic>\n among men who have sex with men (MSM). We examined trends in antimicrobial resistance among MSM, stratified by HIV and PrEP status, and assessed tetracycline resistance in relation to doxyPEP use. We included all MSM with an\n N. gonorrhoeae<\/jats:italic>\n isolate at Melbourne Sexual Health Centre (MSHC) between 2015 and 2024. Resistance was defined using 2025 EUCAST breakpoints and epidemiological cutoff values. Trends were assessed using the Cochran-Armitage test, and tetracycline resistance was compared between doxyPEP users and non-users using the chi-square test. A total of 11,334 isolates from 6,611 MSM were included. Ceftriaxone resistance remained rare (3\/11,334; 0.03%). The proportion of isolates with acquired azithromycin resistance mechanisms increased from 0.9% (8\/940) in 2015 to 6.4% (102\/1,584) in 2024 (\n P<\/jats:italic>\n trend<\/jats:sub>\n < 0.001), above the 5% level at which the WHO recommends that an antimicrobial no longer be used for empirical treatment. Ciprofloxacin resistance increased substantially, from 18.5% (170\/920) to 55.2% (875\/1,584) (\n P<\/jats:italic>\n trend<\/jats:sub>\n < 0.001), with significant trends in all three groups. Tetracycline resistance, assessable from 2019 onward, was consistently high (around 80%), with no significant trend. Among 1,020 isolates with known doxyPEP status, tetracycline resistance was significantly higher in doxyPEP users than in non-users (89.2% [107\/120] vs 77.2% [695\/900],\n P<\/jats:italic>\n = 0.003). High-level tetracycline resistance (MIC > 8 mg\/L) was also more common among doxyPEP users (54.2% vs 29.7%,\n P<\/jats:italic>\n < 0.001). Ceftriaxone remains effective for empirical gonorrhea treatment among MSM in Melbourne. Rising the proportion of azithromycin non-wild-type raises concerns about its ongoing utility in dual therapy. Higher tetracycline resistance among doxyPEP users, particularly high-level tetracycline resistance, underscores the need to monitor for multidrug-resistant strains as doxyPEP use expands.\n <\/jats:p>\n \n IMPORTANCE<\/jats:title>\n \n Antimicrobial-resistant\n Neisseria gonorrhoeae<\/jats:italic>\n is an urgent global health threat, and the expanding use of doxyPEP among MSM has raised concerns regarding its selective pressure on resistance. Linking a decade of individual-level clinical data to over 11,000 isolates from a major Australian sexual health clinic, we show that the proportion of azithromycin non-wild-type has risen to 6.4%, surpassing the 5% threshold at which the WHO recommends discontinuing an agent for empirical therapy. This finding raises concerns about the ongoing utility of dual ceftriaxone-azithromycin treatment. Furthermore, tetracycline resistance was significantly higher among doxyPEP users, with a disproportionate increase in high-level resistance (MIC >8 mg\/L) that was associated with ciprofloxacin co-resistance. These findings provide timely real-world evidence to inform gonorrhea treatment guidelines and antimicrobial surveillance as doxyPEP implementation expands globally.\n <\/jats:p>\n <\/jats:sec>\n <\/jats:sec>","DOI":"10.1128\/jcm.00965-26","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:00:56Z","timestamp":1790341256000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":0,"title":["Antimicrobial resistance in\n Neisseria gonorrhoeae<\/i>\n among men who have sex with men: a 10-year analysis with implications for doxycycline post-exposure prophylaxis"],"prefix":"10.1128","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5880-5731","authenticated-orcid":true,"given":"Phyu Mon","family":"Latt","sequence":"first","affiliation":[{"name":"Melbourne Sexual Health Centre, Bayside Health","place":["Melbourne, Australia"]},{"id":[{"id":"https:\/\/ror.org\/02bfwt286","id-type":"ROR","asserted-by":"publisher"}],"name":"School of Translational Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University","place":["Melbourne, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2560-3233","authenticated-orcid":true,"given":"Ei T.","family":"Aung","sequence":"additional","affiliation":[{"name":"Melbourne Sexual Health Centre, Bayside Health","place":["Melbourne, Australia"]},{"id":[{"id":"https:\/\/ror.org\/02bfwt286","id-type":"ROR","asserted-by":"publisher"}],"name":"School of Translational Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University","place":["Melbourne, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nyi Nyi","family":"Soe","sequence":"additional","affiliation":[{"name":"Melbourne Sexual Health Centre, Bayside Health","place":["Melbourne, Australia"]},{"id":[{"id":"https:\/\/ror.org\/02bfwt286","id-type":"ROR","asserted-by":"publisher"}],"name":"School of Translational Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University","place":["Melbourne, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norelle L.","family":"Sherry","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01ej9dk98","id-type":"ROR","asserted-by":"publisher"}],"name":"Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology & Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity","place":["Melbourne, Australia"]},{"id":[{"id":"https:\/\/ror.org\/05dbj6g52","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Infectious Diseases & Immunology, Austin Health","place":["Heidelberg, Australia"]},{"id":[{"id":"https:\/\/ror.org\/01ej9dk98","id-type":"ROR","asserted-by":"publisher"}],"name":"Centre for Pathogen Genomics, University of Melbourne","place":["Melbourne, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivette","family":"Aguirre","sequence":"additional","affiliation":[{"name":"Melbourne Sexual Health Centre, Bayside Health","place":["Melbourne, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesna","family":"De Petra","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01ej9dk98","id-type":"ROR","asserted-by":"publisher"}],"name":"Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology & Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity","place":["Melbourne, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9349-3080","authenticated-orcid":true,"given":"Fabian Y. S.","family":"Kong","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01ej9dk98","id-type":"ROR","asserted-by":"publisher"}],"name":"Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne","place":["Melbourne, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5654-896X","authenticated-orcid":true,"given":"Eloise","family":"Williams","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05dbj6g52","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Infectious Diseases & Immunology, Austin Health","place":["Heidelberg, Australia"]},{"id":[{"id":"https:\/\/ror.org\/005bvs909","id-type":"ROR","asserted-by":"publisher"}],"name":"Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity","place":["Melbourne, Australia"]},{"id":[{"id":"https:\/\/ror.org\/01ej9dk98","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity","place":["Melbourne, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Roydhouse","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01ej9dk98","id-type":"ROR","asserted-by":"publisher"}],"name":"Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology & Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity","place":["Melbourne, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1766-0657","authenticated-orcid":true,"given":"Eric P. F.","family":"Chow","sequence":"additional","affiliation":[{"name":"Melbourne Sexual Health Centre, Bayside Health","place":["Melbourne, Australia"]},{"id":[{"id":"https:\/\/ror.org\/02bfwt286","id-type":"ROR","asserted-by":"publisher"}],"name":"School of Translational Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University","place":["Melbourne, Australia"]},{"id":[{"id":"https:\/\/ror.org\/01ej9dk98","id-type":"ROR","asserted-by":"publisher"}],"name":"Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne","place":["Melbourne, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_5_2_2","unstructured":"World Health Organization. 2025. Gonorrhoea (Neisseria gonorrhoeae infection) [Fact sheet]. WHO Geneva. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/gonorrhoea-(neisseria-gonorrhoeae-infection)"},{"key":"e_1_3_5_3_2","volume-title":"HIV, viral hepatitis and sexually transmissible infections in Australia: Annual surveillance report 2025","author":"King J","year":"2025","unstructured":"King J, Kwon JA, Gray R, McManus H, McGregor S. 2025. HIV, viral hepatitis and sexually transmissible infections in Australia: Annual surveillance report 2025. The Kirby Institute, Sydney."},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiae313"},{"key":"e_1_3_5_5_2","unstructured":"World Health Organization. 2024. WHO bacterial priority pathogens list 2024: bacterial pathogens of public health importance to guide research development and strategies to prevent and control antimicrobial resistance. Geneva World Health Organization"},{"key":"e_1_3_5_6_2","unstructured":"Australian Government. 2025. Australia\u2019s National Antimicrobial Resistance Strategy \u2013 2020 and Beyond. Canberra Australia"},{"key":"e_1_3_5_7_2","unstructured":"Australian STI Management Guidelines. 2024. Gonorrhoea: ASHM. Available from: https:\/\/sti.guidelines.org.au\/sexually-transmissible-infections\/gonorrhoea"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1177\/09564624251345195"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6950a6"},{"key":"e_1_3_5_10_2","unstructured":"World Health Organization. 2024. Updated recommendations for the treatment of Neisseria gonorrhoeae Chlamydia trachomatis and Treponema pallidum (syphilis) and new recommendations on syphilis testing and partner services. Geneva World Health Organization"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.33321\/cdi.2025.49.056"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(21)00171-3"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-5-201303050-00004"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00356-0"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.30806"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiag192"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-026-01232-6"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad279"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkad129"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.52258"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01221-19"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1071\/SH18024"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1071\/SH25119"},{"key":"e_1_3_5_24_2","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST). 2025. Breakpoint tables for interpretation of MICs and zone diameters. Version 15.0 2025. Available from: https:\/\/www.eucast.org\/clinical_breakpoints"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2026.31.2.2500965"},{"key":"e_1_3_5_26_2","unstructured":"World Health Organization. 2012. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. Geneva: World Health Organization"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz156"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1177\/09564624211023025"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaf320"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12053-4"},{"key":"e_1_3_5_31_2","unstructured":"European Centre for Disease Prevention and Control. 2024. Gonococcal antimicrobial susceptibility surveillance in the European Union\/European Economic Area 2022. Report No.: TQ-02-24-593-EN-N. ECDC Stockholm"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2025.101663"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkz182"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkad221"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaf591"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2211934"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2024-056208"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.70180"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2024.100871"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jcm.00965-26","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jcm.00965-26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:03:16Z","timestamp":1791982996000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/jcm.00965-26"}},"subtitle":[],"editor":[{"given":"Erik","family":"Munson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,10,14]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,14]]}},"alternative-id":["10.1128\/jcm.00965-26"],"URL":"https:\/\/doi.org\/10.1128\/jcm.00965-26","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,14]]},"assertion":[{"value":"2026-06-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00965-26"}}